ArticleCancer prevention research (Philadelphia, Pa.)2023

Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort.

Mark E Sherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.